• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Yvonne Schulman, MD

Latest:

The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical Trials

Using an ICD-9-CM code algorithm, the authors effectively identified potentially difficult-to-reach populations for a hypertension clinical trial.



Richard K. Albert, MD

Latest:

Postdischarge Telephone Calls by Hospitalists as a Transitional Care Strategy

Treating hospitalists effectively identify and efficiently address early postdischarge problems through a single, brief telephone encounter.


Stephen K. Rhodes, DMD

Latest:

Dental Capitation Insurance Provider Compensation: A Fair Deal?

A 13-year study of actual compensation amounts and rates paid to solo general dentists by a capitation or managed care type of insurance plan.


for the GRACE Initiative

Latest:

GRACE Principles: Recognizing High-Quality Observational Studies of Comparative Effectiveness

The GRACE principles lay out 3 questions to help healthcare providers, patients, and other decision makers evaluate the quality of noninterventional comparative effectiveness studies.


Walter F. Stewart, PhD

Latest:

Primary Care Diabetes Bundle Management: 3-Year Outcomes for Microvascular and Macrovascular Events

Using a system for primary care management of patients with diabetes may reduce the risk of myocardial infarction, stroke, and retinopathy over a 3-year period.


Arianna Waye, PhD

Latest:

A Systematic Review of Measurement Properties of Instruments Assessing Presenteeism

A systematic review of presenteeism instruments found that most have been validated to some extent, but evidence for criterion validity is virtually absent.


Wendy Yi Xu, PhD, MS

Latest:

When Is a Network Adequate? Consumer Perspectives on Network Adequacy Definitions

The authors assessed what attributes make provider networks adequate in the eyes of consumers, including travel times, inclusive care, and language access.


Gerard F. Anderson, PhD

Latest:

Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib

Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.


Preeti S. Bajaj, PhD

Latest:

Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects

Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.


Enid M. Geyer, MLS, MBA

Latest:

Health Information Technology and the Medical School Curriculum

There are opportunities for and obstacles to adding core biomedical informatics competencies to medical school curricula.





Homa Dastani, PhD

Latest:

Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.


Kyle Hvidsten, MPH

Latest:

Effects of a Medicaid Prior Authorization Policy for Pregabalin

State Medicaid programs’ pregabalin prior authorization accomplished the objective of lower pregabalin utilization; the unintended effects were increased opioid use and increased disease-related healthcare costs.


Huiying Sun, PhD

Latest:

Effect of Management Strategies and Clinical Status on Costs of Care for Advanced HIV

Antiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with especially advanced HIV.



Melea A. Ward, PharmD, MS

Latest:

Pharmacist-Provided Telephonic Medication Therapy Management in an MAPD Plan

Pharmacist-provided telephonic medication therapy management consultations can lead to decreases in total all-cause healthcare expenditures in a Medicare Advantage Prescription Drug plan population.


Jennifer C. Hasche, MSc

Latest:

VHA Pharmacy Use in Veterans With Medicare Drug Coverage

Greater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.


E. John Orav, PhD

Latest:

Hospitals’ Strategies to Reduce Costs and Improve Quality: Survey of Hospital Leaders

Hospitals pursue a broad range of efforts to improve quality, with those participating in bundled payments attempting to reduce postacute care to a greater degree than nonparticipants.


Kathy Shores-Wilson, PhD

Latest:

Voice Response System to Measure Healthcare Costs:A STAR*D Report

Moderate underreporting biases were found when patient responses to an interactive voice response system were compared with medical records in the STAR*D clinical trial.


Bruce Wearda, RPh

Latest:

Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions

Patients receiving postdischarge care from pharmacists had a 28% lower risk of readmission at 30 days and a 31.9% lower risk at 180 days compared with usual care.





Michele Toscano, MS

Latest:

Genomic Testing and Therapies for Breast Cancer in Clinical Practice

Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.


Brenda Beaty, MSPH

Latest:

Cost of Delivering Centralized and Decentralized Reminder/Recall for Vaccinations to Children and Adolescents in an ACO

Centralized reminder/recall (R/R) is less costly to deliver than decentralized R/R for both children and adolescents when implemented for patients within an accountable care organization.



Emilia Javorsky, MPH

Latest:

Evidence-Based Guidelines to Determine Follow-up Intervals: A Call for Action

Evidence-based guidelines are needed to determine appropriate follow-up intervals for chronic medical conditions to maximize the quality of patient care and minimize unnecessary costs.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.